Alpinumisoflavone suppresses tumour growth and metastasis of clear-cell renal cell carcinoma.
Year: 2017
Type: article
Abstract: Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. The present study is aimed to investigate the role of alpinumisoflavone (AIF), a naturally occurring flavonoid compound, in ccRCC and the underlying mechanism. In this study, miR-101 has been identified as a novel therapeutic target, which exerts anti-tumor effect on ccRCC by directly targeting RLIP76. Moreover, our results showed that AIF was able to increase the expression of miR-101 by suppressing Akt signalling. Our findings in this study provided experimental evidence that AIF has the potential to be used as an agent in the treatment of ccRCC.
Source: Europe PMC (PubMed Central)
Authors: Tingting Wang, Yuhua Jiang, Lei Chu, Tianhui Wu, Jie You
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2994868601
